Formerly the practice lead for Bloomberg Law’s Health Law Group, Loughran also brings experience as a former practicing attorney and law clerk. In his Reed Smith role, he monitors health policy developments from federal agencies such as the U.S. Centers for Medicare & Medicaid Services, the HHS Office of Inspector General, the Food and Drug Administration, and from state legislatures and agencies. He provides research and analysis of policy and regulatory changes related to Medicare and Medicaid payment systems, health care fraud and abuse litigation, and pharmaceutical manufacturing and distribution. He also serves as editor of the firm’s “Health Industry Washington Watch” blog.
“Health care policy and regulation is continually evolving, presenting complex issues for our clients,” said Scot T. Hasselman, co-chair of the firm’s global Life Sciences Health Industry Group. “Matt brings deep industry knowledge and a keen understanding of the regulatory and policy issues, as well as the workings of federal and state agencies and the legislative processes that impact the industry. We are thrilled that he has joined the team.”
While at Bloomberg Law, Loughran was lead editor for various health law research portfolios and managed a team of content specialists to maintain and create content, and research new products for the Bloomberg Law Health Practice Center. He also provided research and analysis of litigation and regulatory developments related to health care law and compliance.